Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
This intro contrasts BTC and ETH to show which blockchain is easier for beginners. Learn the essential differences and how to start exploring.
20,377 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A regional war has unsettled energy markets, prompting a global push toward remote work. Observers say iran reviving ...
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
Sarah Jessica Parker’s journey from a large, struggling family to a $200 million fortune highlights how grit and ambi...
Reno has overtaken Las Vegas as the top destination for California homebuyers seeking affordability, driven by supply...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...
A major fund exits a Buckle stake, triggering questions about strategy and market signals. This article breaks down w...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
Honda is recalibrating its EV plan amid slower demand, while REV Group seals a Terex acquisition, creating a pivotal ...
Tate Ferdinand makes a candid return to Kate Ferdinand’s Blended podcast to talk about life inside a blended family. ...
Wedbush boosts its Micron price target to $500, arguing demand remains healthy after the Chinese New Year. The upgrad...